Langerhans cells in skin lesions of leprosy

Iranian Journal of Medical Sciences

Volumn 29, Issue 2, 2004, Pages 51-55

  Azadeh, B ^a,c   Dabiri, S ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Dendritic cells; Langerhans cells; Leprosy

Indexed keywords

PROTEIN S 100;

ARTICLE; BORDERLINE LEPROSY; BORDERLINE TUBERCULOID LEPROSY; CELL COUNT; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; DERMIS; EPIDERMIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; LEPROMATOUS LEPROSY; LEPROSY; MAJOR CLINICAL STUDY; PATHOGENESIS; PUNCH BIOPSY; SKIN BIOPSY; SKIN MANIFESTATION; TUBERCULOID LEPROSY;

EID: 10644266884     PISSN: 02530716     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ridley DS and Jopling WH. Histologic classification and immunologic spectrum of leprosy. Bull WHO 1974; 51: 451-465.
2. Abulafia J and Vignale RA. Leprosy: pathogenesis updated. Int J Dermatol 1999; 38: 321-34.
3. Bauer J, Bahmer FA, Worl J, et al. A striking constant ratio exists between Langerhans cells and other epidermal cells in human skin. A stereological study using the optical disector method and the confocal laser scanning microscope. J Invest Dermatol 2001; 116: 313-318.
4. Pieri L, Domenici L, Romagnoli P. Langerhans cells differentiation: a three-act play. Ital J Anat Embryol 2001; 106: 47-69.
5. Mahmood SF, Azadeh B. Leprosy in Qatar. Int J Dermatol 1991; 30: 125-126.
6. Prieto VG, Sadick NS and McNutt NS. Quantitative immunohistochemical differences in Langerhans cells in dermatitis due to internal versus external antigen sources. J Cutan Pathol 1998; 25: 301-10.
7. Narayanan RB, Girdhar BK, Lavania RK, et al. In vitro studies on dermal granulomas of human leprosy: characterization of cells using monoclonal antibodies. Int J Lepr Other Mycobact Dis 1986; 54: 268-72.
8. Yamamura M, Uyemura K, Deans RJ, et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254: 277-9.
9. Sehgal VN, Joginder, Sharma VK. Immunology of leprosy. A comprehensive survey. Int J Dermatol 1989; 28: 574-84.
10. Kaplan G. The efficacy of a cell-mediated reaction in the disposal of M. leprae in human skin. Immunol Lett 1988; 19: 223-7.
11. Damasco MH, Sarno EN, Lobao AS, et al. Effect of cutaneous cell-mediated immune response to rlFN gamma on mycobacterium. leprae viability in the lesions of lepromatous leprosy. Braz J Med Biol Res 1992; 25: 457-65.
12. Modlin RL. Th1-Th2 paradigm: insights from leprosy. J Invest Dermatol 1994; 102: 828-32.
13. Sehgal VN, Gupta RP, Kramakar S, et al. In situ characterisation of lymphocytic immunophenotypes and interleukin-2 receptors in cutaneous tuberculosis and leprosy: a comparative evaluation. Clin Exp Dermatol 1994; 19: 312-16.
14. Howe RC, Wondimu A Demissee A, et al. Functional heterogeneity among CD4+ T-cell clones from blood and skin of leprosy patients. Identification of T-cell clones distinct from Tho, Th1 and Th2. Immunology 1995;84:585-94.
15. Cuevas-Santos J, Contreras F, McNutt NS. Multibacillary leprosy lesions with macrophages positive for Factor 13a. J Cutan Pathol 1998; 25: 530-37.
16. Gimenez MF, Gigli I, and Tausk FA. Differential expression of Langerhans cells in the epidermis of patients with leprosy. Br J Dermatol 1989; 121: 19-26.
17. Hashimoto K, Maeda Y, Kimura H, et al. Mycobacterium leprae infection in monocyte-derived dendritic cells and its influence on antigen-presenting function. Infect Immun 2002; 70: 5167-76.
18. Mariotti S, Teloni R, Iona E, et al. Mycobacterium tuberculosis subverts the differentiation of human monocytes into dendritic cells. Eur J Immunol 2002; 32: 3050-8